• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
SDX

SIENNA CANCER DIAGNOSTICS LIMITED - News & Media

0.00% ! 7.0¢
Currently unlisted. Proposed listing date: 3 AUGUST 2017 11:00AM AEST

Sienna Cancer Diagnostics Limited is an Australia-based biotechnology company. The... Sienna Cancer Diagnostics Limited is an Australia-based biotechnology company. The Company is focused on the development and commercialization of novel in vitro diagnostic (IVD) tests for detection and monitoring of cancer. The Company manufactures IVD products for pathology laboratories to use in testing services. The Company’s product Anti-human telomerase reverse transcriptase (hTERT) antibody (SCD-A7) is based on a technology for the detection of biomarker telomerase.The hTERT can be used in pathology labs. Anti-hTERT is targeted against hTERT protein component of the telomerase complex which acts to extend and maintain telomeres in cells.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

No News & Media currently available.

Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.